ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 572,67
-0,79%
Dow Jones
40 211,72
0,00%
DAX
18 486,93
-0,61%
Brent Oil
83,075
-1,50%
Bitcoin
63 984,64
-1,34%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Hutchison China Meditech Ltd (0J7G)

  7. Hutchison China Meditech Ltd (0J7G) Actualités

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0J7G
DateHeureSourceTitreSymboleSociété
25/11/201908h01RNS Non-RegulatoryHutchison China Meditech Limited Surufatinib granted FDA orphan drug designationLSE:0J7GHutchison China Meditech Ltd
11/11/201908h00RNS Non-RegulatoryHutchison China Meditech Limited Surufatinib China NDA acceptanceLSE:0J7GHutchison China Meditech Ltd
17/10/201908h26RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Ph II gastric cancer data for SavolitinibLSE:0J7GHutchison China Meditech Ltd
10/10/201911h22UK RegulatoryHutchison China Meditech Limited Grant of share options under share option schemeLSE:0J7GHutchison China Meditech Ltd
10/10/201910h00RNS Non-RegulatoryHutchison China Meditech Limited Innovent and Chi-Med Expand Global CollaborationLSE:0J7GHutchison China Meditech Ltd
04/10/201908h11RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Phase I/Ib Trial of HMPL-523 in LymphomaLSE:0J7GHutchison China Meditech Ltd
03/10/201909h26UK RegulatoryHutchison China Meditech Limited Holding(s) in CompanyLSE:0J7GHutchison China Meditech Ltd
30/09/201908h03RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Surufatinib Phase III data at ESMOLSE:0J7GHutchison China Meditech Ltd
30/09/201908h00UK RegulatoryHutchison China Meditech Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
25/09/201908h01RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Presents SANET-ep Phase III data at ESMOLSE:0J7GHutchison China Meditech Ltd
18/09/201908h01RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Highlights Presentations at 2019 CSCOLSE:0J7GHutchison China Meditech Ltd
03/09/201908h19RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med to present at MS conferenceLSE:0J7GHutchison China Meditech Ltd
03/09/201908h01UK RegulatoryHutchison China Meditech Limited Chi-Med initiates Phase I trialLSE:0J7GHutchison China Meditech Ltd
23/08/201908h00UK RegulatoryHutchison China Meditech Limited Start of Clinical Trial in ChinaLSE:0J7GHutchison China Meditech Ltd
30/07/201911h48UK RegulatoryHutchison China Meditech Limited TR-1: Form for notification of major holdingsLSE:0J7GHutchison China Meditech Ltd
30/07/201908h02UK RegulatoryHutchison China Meditech Limited 2019 Interim Results and Clinical Programs UpdateLSE:0J7GHutchison China Meditech Ltd
10/07/201917h35UK RegulatoryHutchison China Meditech Limited Price Monitoring ExtensionLSE:0J7GHutchison China Meditech Ltd
03/07/201908h00UK RegulatoryHutchison China Meditech Limited Chi-Med to Announce 2019 Half-Year ResultsLSE:0J7GHutchison China Meditech Ltd
28/06/201912h10UK RegulatoryHutchison China Meditech Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
28/06/201911h07UK RegulatoryHutchison China Meditech Limited Pricing of U.S. Public Secondary Offering of ADSsLSE:0J7GHutchison China Meditech Ltd
28/06/201908h01UK RegulatoryHutchison China Meditech Limited Secondary Offering of American Depositary SharesLSE:0J7GHutchison China Meditech Ltd
21/06/201917h40UK RegulatoryHutchison China Meditech Limited Second Price Monitoring ExtnLSE:0J7GHutchison China Meditech Ltd
14/06/201910h00UK RegulatoryHutchison China Meditech Limited Surufatinib Phase III Study Meets Primary EndpointLSE:0J7GHutchison China Meditech Ltd
12/06/201910h18UK RegulatoryHutchison China Meditech Limited Block Admission Applications & Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
06/06/201908h01UK RegulatoryHutchison China Meditech Limited Disclosure UpdateLSE:0J7GHutchison China Meditech Ltd
29/05/201913h06UK RegulatoryHutchison China Meditech Limited Results of Extraordinary General MeetingLSE:0J7GHutchison China Meditech Ltd
22/05/201912h03UK RegulatoryHutchison China Meditech Limited Grant of Share Options under Share Option SchemeLSE:0J7GHutchison China Meditech Ltd
29/03/201908h02RNS Non-RegulatoryHutchison China Meditech Limited Start of Phase IIb/III Surufatinib Trial in ChinaLSE:0J7GHutchison China Meditech Ltd
28/03/201908h30RNS Non-RegulatoryHutchison China Meditech Limited Savolitinib Lung Cancer Presentations at AACRLSE:0J7GHutchison China Meditech Ltd
11/03/201913h54RNS Non-RegulatoryHutchison China Meditech Limited Publication of Form 20-FLSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G

Dernières Valeurs Consultées

NYSE
JPM
JP Morgan Chase
EU
VK
Vallourec
EU
AI
Air Liquide
EU
VIV
Vivendi
EU
ML
Michelin
EU
BN
Danone
EU
PX4
SBF 120
USI
USTECH100
US Tech 100
EU
RI
Pernod Ricard
EU
SGO
Cie de SaintGobain
COIN
ETHUSD
Ethereum
EU
HO
Thales
EU
CAP
Capgemini
NASDAQ
MSFT
Microsoft
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés